299 related articles for article (PubMed ID: 31951003)
21. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Hohara focus of the Kii Peninsula: A multiple proteinopathy?
Mimuro M; Yoshida M; Kuzuhara S; Kokubo Y
Neuropathology; 2018 Feb; 38(1):98-107. PubMed ID: 29063640
[TBL] [Abstract][Full Text] [Related]
22. Pathway from TDP-43-Related Pathology to Neuronal Dysfunction in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.
Riku Y; Seilhean D; Duyckaerts C; Boluda S; Iguchi Y; Ishigaki S; Iwasaki Y; Yoshida M; Sobue G; Katsuno M
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917673
[TBL] [Abstract][Full Text] [Related]
23. Cortical influences drive amyotrophic lateral sclerosis.
Eisen A; Braak H; Del Tredici K; Lemon R; Ludolph AC; Kiernan MC
J Neurol Neurosurg Psychiatry; 2017 Nov; 88(11):917-924. PubMed ID: 28710326
[TBL] [Abstract][Full Text] [Related]
24. [FTLD/ALS as TDP-43 proteinopathies].
Ishihara T; Ariizumi Y; Shiga A; Yokoseki A; Sato T; Toyoshima Y; Kakita A; Takahashi H; Nishizawa M; Onodera O
Rinsho Shinkeigaku; 2010 Nov; 50(11):1022-4. PubMed ID: 21921552
[TBL] [Abstract][Full Text] [Related]
25. Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis.
Brettschneider J; Libon DJ; Toledo JB; Xie SX; McCluskey L; Elman L; Geser F; Lee VM; Grossman M; Trojanowski JQ
Acta Neuropathol; 2012 Mar; 123(3):395-407. PubMed ID: 22210083
[TBL] [Abstract][Full Text] [Related]
26. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72.
Cooper-Knock J; Hewitt C; Highley JR; Brockington A; Milano A; Man S; Martindale J; Hartley J; Walsh T; Gelsthorpe C; Baxter L; Forster G; Fox M; Bury J; Mok K; McDermott CJ; Traynor BJ; Kirby J; Wharton SB; Ince PG; Hardy J; Shaw PJ
Brain; 2012 Mar; 135(Pt 3):751-64. PubMed ID: 22366792
[TBL] [Abstract][Full Text] [Related]
27. Oligogenic inheritance of optineurin (OPTN) and C9ORF72 mutations in ALS highlights localisation of OPTN in the TDP-43-negative inclusions of C9ORF72-ALS.
Bury JJ; Highley JR; Cooper-Knock J; Goodall EF; Higginbottom A; McDermott CJ; Ince PG; Shaw PJ; Kirby J
Neuropathology; 2016 Apr; 36(2):125-34. PubMed ID: 26303227
[TBL] [Abstract][Full Text] [Related]
28. Sporadic amyotrophic lateral sclerosis with pallido-nigro-luysian degeneration: a TDP-43 immunohistochemical study.
Miki Y; Mori F; Nunomura J; Ookawa K; Yajima N; Yagihashi S; Wakabayashi K
Neuropathology; 2010 Apr; 30(2):149-53. PubMed ID: 19703266
[TBL] [Abstract][Full Text] [Related]
29. Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid.
Bigio EH; Wu JY; Deng HX; Bit-Ivan EN; Mao Q; Ganti R; Peterson M; Siddique N; Geula C; Siddique T; Mesulam M
Acta Neuropathol; 2013 Mar; 125(3):463-5. PubMed ID: 23378033
[No Abstract] [Full Text] [Related]
30. Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders.
Hortobágyi T; Troakes C; Nishimura AL; Vance C; van Swieten JC; Seelaar H; King A; Al-Sarraj S; Rogelj B; Shaw CE
Acta Neuropathol; 2011 Apr; 121(4):519-27. PubMed ID: 21360076
[TBL] [Abstract][Full Text] [Related]
31. Sporadic amyotrophic lateral sclerosis of long duration is associated with relatively mild TDP-43 pathology.
Nishihira Y; Tan CF; Hoshi Y; Iwanaga K; Yamada M; Kawachi I; Tsujihata M; Hozumi I; Morita T; Onodera O; Nishizawa M; Kakita A; Takahashi H
Acta Neuropathol; 2009 Jan; 117(1):45-53. PubMed ID: 18923836
[TBL] [Abstract][Full Text] [Related]
32. Clinical and pathological continuum of multisystem TDP-43 proteinopathies.
Geser F; Martinez-Lage M; Robinson J; Uryu K; Neumann M; Brandmeir NJ; Xie SX; Kwong LK; Elman L; McCluskey L; Clark CM; Malunda J; Miller BL; Zimmerman EA; Qian J; Van Deerlin V; Grossman M; Lee VM; Trojanowski JQ
Arch Neurol; 2009 Feb; 66(2):180-9. PubMed ID: 19204154
[TBL] [Abstract][Full Text] [Related]
33. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Arai T; Hasegawa M; Akiyama H; Ikeda K; Nonaka T; Mori H; Mann D; Tsuchiya K; Yoshida M; Hashizume Y; Oda T
Biochem Biophys Res Commun; 2006 Dec; 351(3):602-11. PubMed ID: 17084815
[TBL] [Abstract][Full Text] [Related]
34. Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale).
Smith RA; Macklin EA; Myers KJ; Pattee GL; Goslin KL; Meekins GD; Green JR; Shefner JM; Pioro EP
Eur J Neurol; 2018 Jul; 25(7):907-e66. PubMed ID: 29577526
[TBL] [Abstract][Full Text] [Related]
35. The neuropathology of FTD associated With ALS.
Mackenzie IR
Alzheimer Dis Assoc Disord; 2007; 21(4):S44-9. PubMed ID: 18090423
[TBL] [Abstract][Full Text] [Related]
36. The frontotemporal syndromes of ALS. Clinicopathological correlates.
Strong MJ; Yang W
J Mol Neurosci; 2011 Nov; 45(3):648-55. PubMed ID: 21809041
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43.
King A; Maekawa S; Bodi I; Troakes C; Al-Sarraj S
Neuropathology; 2011 Jun; 31(3):239-49. PubMed ID: 21118398
[TBL] [Abstract][Full Text] [Related]
38. TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia.
Halliday GM; Kiernan MC; Kril JJ; Mito R; Masuda-Suzukake M; Hasegawa M; McCann H; Bartley L; Dobson-Stone C; Kwok JBJ; Hornberger M; Hodges JR; Tan RH
J Neurol Sci; 2016 Jul; 366():197-201. PubMed ID: 27288806
[TBL] [Abstract][Full Text] [Related]
39. Pathological and immunoblot analysis of phosphorylated TDP-43 in sporadic amyotrophic lateral sclerosis with pallido-nigro-luysian degeneration.
Uchino A; Ogino M; Takahashi-Fujigasaki J; Oonuma S; Kanazawa N; Kajita S; Ichinoe M; Hasegawa M; Nishiyama K; Murayama S
Neuropathology; 2018 Apr; 38(2):171-178. PubMed ID: 28906030
[TBL] [Abstract][Full Text] [Related]
40. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation.
Tan CF; Eguchi H; Tagawa A; Onodera O; Iwasaki T; Tsujino A; Nishizawa M; Kakita A; Takahashi H
Acta Neuropathol; 2007 May; 113(5):535-42. PubMed ID: 17333220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
